Enzymaster
PrivateLast Round
Series C
May 12, 2022
Total Funding Raised
$52.5M
Company Overview
Enzymaster operates in Healthcare & Life Sciences and is based in Ningbo. Its latest recorded funding round was a Series C round in May 2022.
Enzymaster is a biotechnology company that provides biocatalysis solutions. The company specializes in enzyme and strain-related catalysis technology, including enzyme evolution, strain modification, enzyme fermentation, and industrial production, serving sectors such as pharmaceutical engineering, fine chemicals, new materials, and environmental protection.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Smart Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enzymaster Comparables
Compare Enzymaster with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 弈柯莱生物科技（集团）股份有限公司 | 83% | |
| Codexis | 82% | |
| Huili Bio | 81% |
For institutional investors. Book with your work email.
Enzymaster Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 12, 2022 | ||||
| Series B | Oct 19, 2020 | ||||
| Series A | Jan 31, 2018 |
For institutional investors. Book with your work email.
Enzymaster Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriental Fortune Capital | Series A |
| YuanBio Venture Capital | Series C |
| Xiamen C&D Emerging Industry Equity Investment | Series C |
| Puhua Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 816% MoM, reaching 1.1K.
- Jun 1, 2025
Monthly visitors grew 363% MoM, from 40 to 185.
For institutional investors. Book with your work email.
Enzymaster Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Enzymaster's valuation, stock price, and market status.
Is Enzymaster a public or private company?
Enzymaster is a private company.
What is the current stock price of Enzymaster?
Enzymaster is a private company, so its shares have no public market price. Caplight tracks Enzymaster's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Enzymaster worth (valuation)?
Valuation information for Enzymaster is not publicly available.
Can I buy Enzymaster stock?
Enzymaster shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Enzymaster's last funding round?
Enzymaster's most recent funding round was Series C on May 12, 2022.
Who are the main investors in Enzymaster?
Key investors in Enzymaster include YuanBio Venture Capital.
Will Enzymaster IPO soon?
No public IPO plans have been announced for Enzymaster.
How can I track Enzymaster secondary market activity?
Caplight tracks bids, offers, and trades in Enzymaster's shares on secondary markets.